Nasus Pharma NSRX Balance Sheet (2024-2026)

NYSE NSRX
$3.61 +0.02 (+0.42%)
As of: Sep 29, 2026 · 3:59 PM EDT
Reported Financials

Nasus Pharma Quarterly Balance Sheet

Periods 4 quarters
Latest Jun 2026

Nasus Pharma reported total assets of $12.45M and total liabilities of $1.45M for the quarter ended Jun 2026. This balance sheet covers 4 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Dec2024 Jun2025 Dec2025 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv. 0.31M0.23M1.24M7.82M
Prepaid Assets 0.15M0.06M0.52M0.41M
Current Assets 0.46M0.29M4.86M12.31M
Non-Current Assets
Property, Plant & Equipment (Net) 0.01M0.02M
Other Non-Current Assets 0.03M0.03M0.05M0.09M
Non-Current Assets 0.26M0.35M0.15M0.14M
Assets 0.72M0.64M5.00M12.45M
Liabilities
Current Liabilities
Accounts Payables 0.99M0.66M0.83M0.35M
Payables 0.99M0.66M0.83M0.35M
Accumulated Expenses 0.84M0.55M
Other Accumulated Expenses 0.11M0.83M
Short term Debt 1.80M2.56M
Current Leases 0.04M0.05M
Total Current Liabilities 3.93M4.95M2.16M1.40M
Non-Current Liabilities
Liabilities from Discontinued Operations 0.49M0.55M0.48M0.43M
Operating Leases 0.07M0.05M
Total Liabilities 3.93M4.95M2.24M1.45M
Shareholder's Equity
Total Debt 1.80M2.56M
Common Equity -3.21M-4.31M2.77M11.00M
Liabilities and Shareholders Equity 0.72M0.64M5.00M12.45M
Retained Earnings -12.66M-13.92M-18.52M-24.46M

Nasus Pharma Balance Sheet API

Pull Nasus Pharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=NSRX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY